Atlas Venture Associates IX, LLC - Q1 2022 holdings

$109 Million is the total value of Atlas Venture Associates IX, LLC's 7 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .

 Value Shares↓ Weighting
SKLZ  SKILLZ INC$68,730,000
-59.7%
22,909,8590.0%63.21%
-15.0%
SPRO  SPERO THERAPEUTICS INC$11,980,000
-45.7%
1,376,9680.0%11.02%
+14.5%
SURF  SURFACE ONCOLOGY INC$8,660,000
-38.5%
2,945,4530.0%7.96%
+29.6%
COGT  COGENT BIOSCIENCES INC$6,867,000
-12.7%
916,8320.0%6.32%
+84.0%
SYBX  SYNLOGIC INC$6,364,000
-0.8%
2,651,9630.0%5.85%
+109.0%
SNAP  SNAP INCcl a$5,404,000
-23.5%
150,1600.0%4.97%
+61.2%
NTLA  INTELLIA THERAPEUTICS INC$727,000
-38.5%
10,0000.0%0.67%
+29.7%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTELLIA THERAPEUTICS INC28Q3 2023100.0%
SNAP INC26Q3 202311.4%
SPERO THERAPEUTICS INC24Q3 202324.0%
SYNLOGIC INC24Q2 202335.6%
SURFACE ONCOLOGY INC21Q2 202333.3%
SKILLZ INC12Q3 202387.5%
UNUM THERAPEUTICS INC11Q3 202028.2%
COGENT BIOSCIENCES INC7Q2 20229.6%
CARBON BLACK INC6Q3 20197.8%
COHERUS BIOSCIENCES INC1Q3 202318.1%

View Atlas Venture Associates IX, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04
13F-HR2021-08-11

View Atlas Venture Associates IX, LLC's complete filings history.

Compare quarters

Export Atlas Venture Associates IX, LLC's holdings